tiprankstipranks
Arcus Biosciences Inc (RCUS)
NYSE:RCUS
US Market
Holding RCUS?
Track your performance easily

Arcus Biosciences (RCUS) Ownership - Who Owns Arcus Biosciences?

448 Followers

Arcus Biosciences (RCUS) Ownership Overview

40.74%14.82%15.53%15.61%13.31%
40.74% Insiders
15.53% Other Institutional Investors
15.61% ETFs
13.31% Public Companies and
Individual Investors
The ownership structure of Arcus Biosciences (RCUS) stock is a mix of institutional, retail, and individual investors. Approximately 45.96% of the company’s stock is owned by Institutional Investors, 40.74% is owned by Insiders, and 13.31% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 20, 2024
xxxxxxxxxxxxx
$240941
Jan 31, 2024
xxxxxxxxxxxxx
$319999995

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
30,061,124Insider32.85%471,959,647
6,844,513Institution7.48%107,458,854
4,248,719Institution4.64%66,704,888
4,245,221Institution4.64%66,649,970
3,954,304Insider4.32%62,082,573
3,439,547Institution3.76%54,000,888
3,363,162Institution3.68%52,801,643
1,854,758Institution2.03%29,119,701
1,612,077Institution1.76%25,309,609
1,522,739Insider1.66%23,907,002

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,439,547Institution3.76%54,000,888
3,363,162Institution3.68%52,801,643
693,258Institution0.76%10,884,151
622,416Institution0.68%9,771,931
580,085Institution0.63%9,107,335
557,478Institution0.61%8,752,405
450,000Institution0.49%7,065,000
414,762Institution0.45%6,511,763
379,100Institution0.41%5,951,870
287,282Institution0.31%4,510,327

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,457,873Institution3.78%54,288,606
1,616,463Institution1.77%24,715,719
1,521,673Institution1.66%23,890,266
968,331Institution1.06%15,270,580
848,877Institution0.93%12,979,329
630,221Institution0.69%9,636,079
488,313Institution0.53%7,666,514
485,013Institution0.53%7,648,655
344,495Institution0.38%5,267,329
334,861Institution0.37%5,257,318

FAQ

Who Owns Arcus Biosciences Inc (RCUS)?
According to the latest TipRanks data, approximately 15.53% of the company's stock is held by institutional investors, 40.74% is held by insiders, and 13.31% is held by retail investors.
    What percentage of Arcus Biosciences Inc (RCUS) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 15.53% of Arcus Biosciences Inc (RCUS) stock is held by institutional investors.
      What percentage of Arcus Biosciences Inc (RCUS) stock is held by retail investors?
      According to the latest TipRanks data, approximately 13.31% of Arcus Biosciences Inc (RCUS) stock is held by retail investors.
        Who owns the most shares of Arcus Biosciences Inc (RCUS)?
        Gilead Sciences Inc owns the most shares of Arcus Biosciences Inc (RCUS).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis